Wendy I. White

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

JoAnn Suzich, S. Ghim, Frances J. Palmer‐Hill et al. · Proceedings of the National Academy of Sciences · 1995 · 671 citations

Life Sciences, Immunology, Infectious Diseases +17

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Brandon W. Higgs, Zheng Liu, Barbara White et al. · Annals of the Rheumatic Diseases · 2011 · 408 citations

Life Sciences, Immunology, Molecular Medicine +17

Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract

Herren Wu, David S. Pfarr, Syd Johnson et al. · Journal of Molecular Biology · 2007 · 382 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Sifalimumab, a Human Anti–Interferon‐α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose‐Escalation Study

Michelle Petri, Daniel J. Wallace, Alberto Spindler et al. · Arthritis & Rheumatism · 2013 · 240 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

D. J. Wallace, M. Pétri, Kyriakos A. Kirou et al. · Annals of the Rheumatic Diseases · 2011 · 228 citations

Pharmacy, Immunology, Pharmacology +17